ipamorelin e tesamorelin + Blend — GHRH Research Tesamorelin 10mg — Only FDA-Approved

This peptide is designed to stimulate the release of growth hormone from the pituitary gland in a pulsatile manner, leading to increased levels of growth hormone in the body

Peptide Therapy CJC ipamorelin vs sermorelin compared by mechanism, evidence, dosing, and failure modes

Because Tesamorelin specifically targets abdominal fat while Ipamorelin supports lean mass maintenance, it provides a unique framework for investigating the reversal of metabolic syndrome

Short to medium term use appears safe based on available evidence

Inject both peptides simultaneously for maximum pulse

(The 503A Bulks List is a list of drug substances that the FDA has approved for compounding under section 503A of the Federal Food, Drug, and Cosmetic Act.) If the peptides meet the safety requirements, the committee will recommend reclassifying them onto this list, so they can then be legally prescribed and compounded